Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | CTSS | P25774 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.35 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.35 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.35 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.35 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.35 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.35 |
| ▸ | NPY2R | P49146 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4838597 | 0.81 | CTSL (0.41) | SMN1; SMN2NPC1RAB9APAX8CTSL | |
| SCHEMBL28823423 | 0.78 | TP53 (0.62) | ALDH1A1TP53NPC1JAK2RAB9A | |
| SCHEMBL28039137 | 0.78 | TP53 (0.62) | ALDH1A1TP53NPC1JAK2RAB9A | |
| SCHEMBL28039146 | 0.78 | TP53 (0.62) | ALDH1A1TP53NPC1JAK2RAB9A | |
| SCHEMBL28038889 | 0.78 | TP53 (0.62) | ALDH1A1TP53NPC1JAK2RAB9A | |
| SCHEMBL18661149 | 0.76 | PAX8 (0.45) | SMN1; SMN2NPC1RAB9APAX8CTSL | |
| SCHEMBL29837177 | 0.76 | TP53 (0.43) | ALDH1A1TP53NPC1JAK2RAB9A | |
| SCHEMBL28038837 | 0.75 | KDM4E (0.41) | ALDH1A1TP53NPC1JAK2RAB9A | |
| SCHEMBL28038835 | 0.73 | TP53 (0.54) | ALDH1A1TP53NPC1JAK2RAB9A | |
| SCHEMBL28823462 | 0.73 | NCEH1 (0.41) | ALDH1A1TP53NPC1JAK2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10367143-B2 | Organic semiconducting compounds | MERCK PATENT GMBH (DE) | 2019-07-30 | — | — | US | disclosed |
| US-20170084839-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| US-20170084839-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| US-20170084839-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-03-23 | — | — | US | disclosed |
| EP-3119776-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | Merck Patent GmbH (DE) | 2017-01-25 | — | — | EP | disclosed |
| WO-2015139802-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2015-09-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170084839-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | PPOX, OSTC, OCIAD1 | SMN1; SMN2 4766/4885ALDH1A1 2904/4885TP53 2499/4885 |
| US-10367143-B2 | Organic semiconducting compounds | PPOX, OSTC, OCIAD1 | SMN1; SMN2 4766/4885ALDH1A1 2904/4885TP53 2499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.